Stryker CorporationFirst hip arthroscopy performed using Stryker's FDA-cleared SportSuite Vision app on Apple Vision Pro, marking real-world clinical adoption of its new surgical platform.

Stryker announced the successful completion of the first hip arthroscopy procedure using its SportSuite Vision application on Apple Vision Pro at Duke Health, following the FDA's De Novo authorization in July, making it the first surgical application approved for intraoperative use with Apple's mixed reality headset. The procedure was performed by orthopedic surgeon Chad Mather III, demonstrating the platform's transition from regulatory clearance to real-world clinical adoption. SportSuite Vision is designed for femoroacetabular impingement and labral repair procedures, combining arthroscopic video, HipCheck, HipMap FAI Analysis, and CT imaging in a customizable spatial computing environment. While the launch is unlikely to materially affect near-term revenue, it could enhance Stryker's competitive position and support long-term growth as hospitals adopt advanced operating room technologies. Shares of Stryker traded flat on Wednesday, and year to date, the stock has lost 11.1% compared with the industry's 17% decline, while the S&P 500 has risen 10.9%. Stryker also recently agreed to acquire ZuriMED, developer of the FiberLocker System for rotator cuff augmentation, to strengthen its shoulder portfolio.
Stryker CorporationFirst hip arthroscopy performed using Stryker's FDA-cleared SportSuite Vision app on Apple Vision Pro, marking real-world clinical adoption of its new surgical platform.
Globus Medical
Apple Inc.
Applovin Corp
The Cooper Companies, Inc
West Pharmaceutical Services Inc